4//SEC Filing
Dhanak Dashyant 4
Accession 0001209191-22-041062
CIK 0000879169other
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:06 PM ET
Size
9.7 KB
Accession
0001209191-22-041062
Insider Transaction Report
Form 4
INCYTE CORPINCY
Dhanak Dashyant
EVP & Chief Scientific Officer
Transactions
- Award
Common Stock
2022-07-02+11,274→ 53,416 total - Award
Employee Stock Option (right to buy)
2022-07-02+15,277→ 15,277 totalExercise: $77.67Exp: 2032-07-01→ Common Stock (15,277 underlying) - Tax Payment
Common Stock
2022-07-05$79.25/sh−2,181$172,844→ 51,235 total
Footnotes (4)
- [F1]Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Dashyant Dhanak's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- [F2]Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock.
- [F3]Including the July 2, 2022 RSU Grant, this includes an aggregate of 26,997 shares of common stock issuable pursuant to previously reported RSUs and earned performance shares that have not vested.
- [F4]Beginning July 2, 2022, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Documents
Issuer
INCYTE CORP
CIK 0000879169
Entity typeother
Related Parties
1- filerCIK 0001760682
Filing Metadata
- Form type
- 4
- Filed
- Jul 5, 8:00 PM ET
- Accepted
- Jul 6, 4:06 PM ET
- Size
- 9.7 KB